NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)
South Korea · Delayed Price · Currency is KRW 2,395.00
+25.00 (1.05%)
At close: Sep 15, 2025
NEXTURNBIOSCIENCE Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 37,869 | 31,640 | 41,258 | 23,463 | 16,972 | 9,685 | Upgrade | |
Revenue Growth (YoY) | 4.56% | -23.31% | 75.84% | 38.24% | 75.24% | -61.43% | Upgrade |
Cost of Revenue | 27,926 | 24,879 | 32,137 | 18,114 | 12,228 | 7,548 | Upgrade |
Gross Profit | 9,944 | 6,762 | 9,121 | 5,349 | 4,744 | 2,137 | Upgrade |
Selling, General & Admin | 7,234 | 5,331 | 5,358 | 6,219 | 5,242 | 2,180 | Upgrade |
Research & Development | 469.29 | 444.33 | 483.4 | 893.45 | 916.16 | 1,021 | Upgrade |
Other Operating Expenses | 503.03 | 489.47 | 504.47 | 506.17 | 221.07 | 146.33 | Upgrade |
Operating Expenses | 9,947 | 8,208 | 10,391 | 9,879 | 7,134 | 5,155 | Upgrade |
Operating Income | -3.62 | -1,446 | -1,271 | -4,529 | -2,390 | -3,018 | Upgrade |
Interest Expense | -5,435 | -5,465 | -4,076 | -5,667 | -2,416 | -1.04 | Upgrade |
Interest & Investment Income | 6,650 | 6,589 | 6,307 | 6,179 | 1,851 | 497.94 | Upgrade |
Earnings From Equity Investments | -11,981 | - | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -310.35 | 961.52 | 430.1 | 189.89 | 1,249 | -1,643 | Upgrade |
Other Non Operating Income (Expenses) | 22,022 | 1,312 | -5,211 | 641.75 | 751.38 | 389.4 | Upgrade |
EBT Excluding Unusual Items | 10,942 | 1,953 | -3,820 | -3,186 | -953.76 | -3,774 | Upgrade |
Gain (Loss) on Sale of Investments | -9,921 | -15,419 | 21,292 | -3,815 | -3,067 | 343.42 | Upgrade |
Gain (Loss) on Sale of Assets | -60.49 | 50.88 | 57.76 | 2,351 | 23.71 | 0.95 | Upgrade |
Asset Writedown | - | - | -645 | - | - | - | Upgrade |
Other Unusual Items | -1,241 | -1,016 | 38.54 | 11.13 | - | - | Upgrade |
Pretax Income | -280.85 | -14,432 | 16,923 | -4,639 | -3,997 | -3,430 | Upgrade |
Income Tax Expense | -1,133 | -1,427 | 7,648 | 240.12 | 435.54 | -993.76 | Upgrade |
Earnings From Continuing Operations | 852.29 | -13,005 | 9,275 | -4,879 | -4,433 | -2,436 | Upgrade |
Earnings From Discontinued Operations | - | - | 406.33 | 190.43 | - | - | Upgrade |
Net Income | -515.2 | -13,005 | 9,681 | -4,688 | -4,433 | -2,436 | Upgrade |
Net Income to Common | -515.2 | -13,005 | 9,681 | -4,688 | -4,433 | -2,436 | Upgrade |
Shares Outstanding (Basic) | 12 | 11 | 9 | 7 | 6 | 6 | Upgrade |
Shares Outstanding (Diluted) | 12 | 11 | 10 | 7 | 6 | 6 | Upgrade |
Shares Change (YoY) | 23.97% | 8.38% | 48.59% | 5.86% | - | - | Upgrade |
EPS (Basic) | -42.37 | -1189.64 | 1086.74 | -690.64 | -691.28 | -379.94 | Upgrade |
EPS (Diluted) | -42.37 | -1190.00 | 885.38 | -690.95 | -691.28 | -380.00 | Upgrade |
Free Cash Flow | 3,150 | -1,788 | -3,047 | -1,407 | 3,197 | -979.05 | Upgrade |
Free Cash Flow Per Share | 259.10 | -163.53 | -302.11 | -207.29 | 498.56 | -152.68 | Upgrade |
Gross Margin | 26.26% | 21.37% | 22.11% | 22.80% | 27.95% | 22.07% | Upgrade |
Operating Margin | -0.01% | -4.57% | -3.08% | -19.30% | -14.08% | -31.16% | Upgrade |
Profit Margin | -1.36% | -41.10% | 23.46% | -19.98% | -26.12% | -25.15% | Upgrade |
Free Cash Flow Margin | 8.32% | -5.65% | -7.39% | -6.00% | 18.84% | -10.11% | Upgrade |
EBITDA | 2,368 | 567.07 | 731.84 | -2,721 | -1,338 | -2,503 | Upgrade |
EBITDA Margin | 6.25% | 1.79% | 1.77% | -11.60% | -7.89% | -25.85% | Upgrade |
D&A For EBITDA | 2,372 | 2,013 | 2,002 | 1,808 | 1,051 | 514.56 | Upgrade |
EBIT | -3.62 | -1,446 | -1,271 | -4,529 | -2,390 | -3,018 | Upgrade |
EBIT Margin | -0.01% | -4.57% | -3.08% | -19.30% | -14.08% | -31.16% | Upgrade |
Effective Tax Rate | - | - | 45.20% | - | - | - | Upgrade |
Advertising Expenses | - | 116.74 | 26 | 163.43 | 176.3 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.